Periodic Labs Secures $200M to Revolutionize Foot & Ankle Care in Chicagoland

Periodic Labs is thrilled to announce a milestone funding event, having raised a total of $200,000,000 to empower our mission of advancing patient care and outcomes in the Greater Chicagoland Area. As an independent medical distributor specializing in foot and ankle solutions, our dedication to improving the quality of life for patients is at the heart of everything we do. This infusion of capital will enable us to expand our operations, modernize our distribution channels, and further our commitment to introducing cutting-edge technologies and advancements in foot and ankle care. Representing leading hardware lines such as Enovis and Medline, along with specialty products like Conventus Flower and Restor3d, and wound care solutions from Bone Support, Acera Surgical, and Biocomposites, we have cultivated strong partnerships with trusted manufacturers. In addition, our biologics division proudly features Induce XT, a testament to our comprehensive, multi-faceted approach to patient care. Our strategic vision centers on building even stronger alliances with innovators and healthcare professionals. This funding will allow us to enhance our product offerings to meet the ever-evolving challenges faced by physicians and improve overall patient outcomes. By investing in state-of-the-art technologies and streamlining our supply chain processes, Periodic Labs is poised to deliver transformative medical solutions with greater speed and efficacy. We remain unwavering in our belief that collaboration, agility, and patient-centric care are the foundations of significant and lasting impact. As we embark on this next chapter of growth and innovation, we invite our partners, physicians, and community stakeholders to join us in driving forward a future where every step toward improved foot and ankle health is a step toward a brighter, healthier tomorrow.